Latest Headlines

  1. Abbott Launches SimpleScreen™ CRC Blood Test, Joining Cologuard Plus® In Its Colorectal Cancer Screening Portfolio 9/30/2026

    Abbott (NYSE: ABT) today announced the U.S. commercial launch of SimpleScreen™ CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for the disease.

  2. NovoPath Comes To Market With The Next-Generation LIS That Has The Digital Pathology Workflow Built In. One Platform, One Workflow, One Source Of Truth For Pathologists, The Lab, And The Business 9/30/2026

    NovoPath today introduced the next generation of its laboratory information system, the software that runs a pathology laboratory from specimen to report, with the digital pathology workflow built in.

  3. EpiSign Launches METRIC 5-Base, Enabling Comprehensive Episignature Analysis Across Genome-Sequencing Platforms 9/30/2026

    EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA methylation data.

  4. Roche Launches Newborn Screening Test For Three Severe Genetic Conditions 9/30/2026

    Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an in vitro diagnostic test for newborn screening in countries accepting the CE mark.

  5. Caris Life Sciences Unveils The Next Evolution Of Liquid Biopsy With Enhanced Caris Assure 9/29/2026

    Caris Life Sciences® (Caris), a leading AI TechBio company, today unveiled the enhanced Caris Assure®, a new evolution of liquid biopsy. By integrating Whole Exome Sequencing (WES), Whole Transcriptome Sequencing (WTS) and whole-blood analysis (for true CHIP identification) into a single platform, the enhanced Caris Assure assay provides a more complete molecular profile from a single blood draw, delivering deeper insights to help guide precision oncology decisions.

  6. VB Spine Announces FDA Breakthrough Device Designation For New Blood Test Designed To Identify Patients At Risk For Scoliosis Progression 9/29/2026

    VB Spine LLC (“VB Spine”), the largest privately-held spine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ScolimiR-3D, an in vitro diagnostic blood test designed to assess the risk of disease progression in patients diagnosed with adolescent idiopathic scoliosis (AIS).

  7. Siemens Healthineers Launches Innovance D-Dimer 2.0 Assay To Help Clinicians Rule Out, Monitor Serious Blood-Clotting Conditions 9/29/2026

    Siemens Healthineers announced today the global launch of its Innovance D-Dimer 2.0 assay1, which is CE-marked and has received FDA 510(k) clearance. The blood test helps clinicians assess patients with suspected venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE).

  8. Cepheid Receives FDA Clearance For Xpert® Respiratory Panel To Aid In The Diagnosis Of Respiratory Tract Infection 9/29/2026

    Cepheid, a Danaher company, announced today that it has received FDA clearance for the Xpert Respiratory Panel, a multiplex PCR test designed to detect 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab sample.

  9. Leica Biosystems Completes Acquisition Of StatLab To Bolster Delivery Of More Precise, Timely Diagnostics For Cancer Patients 9/28/2026

    Leica Biosystems, a Danaher company (the "Company") and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has completed its acquisition of privately held StatLab Medical Products ("StatLab"), a leading provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Private Equity.

  10. QIAGEN Launches QIAmini To Automate Small-Batch Sample Preparation 9/24/2026

    QIAGEN N.V. today announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and cost-efficient alternative to processing samples by hand.